Richard Peters Yumanity Therapeutics, Inc. (YMTX) insider trading activity

Richard Peters is of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2025, when has been sold 101,891 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Richard Peters Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2025	SELL Sale (or disposition) back to the issuer	-	101,891 Reduced 100.0%	0 Common Stock
Jun 25 2025	BUY Grant, award, or other acquisition	-	6,000 Added 5.56%	101,891 Common Stock
Jun 23 2025	SELL Payment of exercise price or tax liability	$1,223 $0.26 p/Share	4,706 Reduced 4.68%	95,891 Common Stock
Jun 23 2025	BUY Exercise of conversion of derivative security	$7,625 $0.61 p/Share	12,500 Added 11.05%	100,597 Common Stock
Dec 16 2022	SELL Payment of exercise price or tax liability	$3,591 $1.86 p/Share	1,931 Reduced 2.14%	88,097 Common Stock
Dec 02 2022	SELL Open market or private sale	$18,404 $1.69 p/Share	10,890 Reduced 10.79%	90,028 Common Stock
Jul 05 2022	SELL Open market or private sale	$8,480 $1.85 p/Share	4,584 Reduced 4.34%	100,918 Common Stock
Jun 03 2022	SELL Open market or private sale	$12,145 $1.19 p/Share	10,206 Reduced 8.82%	105,502 Common Stock
Mar 28 2022	SELL Open market or private sale	$19,823 $1.85 p/Share	10,715 Reduced 8.48%	115,708 Common Stock
Dec 01 2021	BUY Grant, award, or other acquisition	-	70,000 Added 35.64%	126,423 Common Stock
Jul 06 2021	SELL Payment of exercise price or tax liability	$852 $10.79 p/Share	79 Reduced 0.14%	56,423 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$49,340 $11.11 p/Share	4,441 Reduced 7.29%	56,502 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	60,943 Added 50.0%	60,943 Common Stock

Also insider at

APRE

Aprea Therapeutics, Inc. Healthcare

Director

Richard Peters

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Value

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Track Activities on YMTX

Account